Will You Be a Hero for the Cure? A Blog Entry by Nelson Vergel (May 10, 2011)
"Most of these [HIV cure] studies will present no personal benefit to patients enrolling in them, but they will hopefully appeal to those altruistic enough to take a risk for the greater good and advancement of this important research. Many question themselves as to whether it is ethical to ask patients to take risks ..."
Prepping for a PrEP Trial (July/August 2009)
Why is it so hard to find young people to participate in HIV-related studies? While trying to find an assistant to help recruit young, gay men for a trial of pre-exposure HIV prophylaxis (PrEP), HIV advocate Keith Green may have stumbled on an answer: homophobia.
To read PDF, click here.
In Positively Aware, from Positively Aware
After 25 Years, a Landmark HIV Study Is Still Going Strong (April 25, 2009)
The Multicenter AIDS Cohort Study (MACS) is one for the history books: It's one of the most important HIV/AIDS studies ever done, and over the past 25 years it has brought about many major discoveries.
From National Public Radio
The Body is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.